Canadian Pension Health Remains Strong Despite Brexit, but

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Canadian Pension Health Remains Strong Despite Brexit, but Interest Rate Risk Deepens: Aon Survey

TORONTO, ON --(Marketwired - July 05, 2016) - Aon Hewitt , the global talent, retirement and health solutions business of Aon plc ( NYSE : AON ), today released results of its pension plan solvency survey for the second quarter of 2016, which found that the health of Canadian defined benefit (DB) pensions improved quarter-over-quarter despite the recent headwinds from Brexit. Through June 30, overall pension solvency of those plans surveyed rose by 2.3 percentage points in the quarter, as the immediate selloff in equities following Britain's vote to leave the European Union reversed in the last week of June. Going forward in the post-Brexit world, however, lower bond yields and the prospect of heightened market volatility continue to cloud the outlook for pension solvency.

The Aon survey, which measures plans' assets over liabilities to calculate their solvency funded ratio, is based on results from a total of 449 Aon Hewitt-administered DB pensions from the public, semi-public and private sectors. Median solvency on June 30, 2016, was 85.4%, compared with 83.1% at the end of the previous quarter and 87.1% as of June 1.

Aon's data suggest that the short-term impact of the UK referendum -- including the biggest two-day stock rout in history -- may already be subsiding. In the 48 hours after the vote result, overall pension solvency declined from pre-Brexit levels by as much as 1.7 percentage points, but recovered substantially as stock markets rallied last week. By quarter-end, 9.1% of surveyed plans were fully funded, an increase of more than a percentage point from the fully funded ratio in the first quarter (8%).

"Brexit understandably created a lot of anxiety around the state of the global economy and the destabilizing effect of nationalist movements, but the reality is that the event itself had minimal short-term impact on our pension clients, who think long-term," said Ian Struthers, Partner, and Investment Consulting Practice Director at Aon Hewitt. "However, we believe the continued decline in bond yields, which is likely only to be aggravated in a post-Brexit world, highlights a longer-term challenge for pensions, and represents a risk factor that plan sponsors need to have a position on and address."

Beyond the equity selloff, Brexit sparked a rally in government bonds as investors fled to safety. Bond yields (which are inverse to prices) plummeted. Lower yields adversely affect pension solvency, as they effectively lower the discount rate that plan sponsors apply to liabilities. Between June 23 and June 29, the yield on Government of Canada benchmark 10-year bonds declined by 18 basis points. Plan solvency over the quarter still improved, but largely because of an actuarial change that dampened the impact of lower yields: the Canadian Institute of Actuaries introduced new guidance in May increasing the credit spreads over benchmark bonds that plan sponsors can apply when calculating solvency.

A critical issue, though, is that unlike the reversal of the equity selloff, the rally in bonds has not reversed significantly since the referendum. In fact, Brexit seems only to have aggravated a long-term decline in bond yields. From January 1, 2014 to the end of Q2 2016, the yield on Canada benchmark 10-year bonds fell by more than 160 basis points (see chart below). On a global basis, yield suppression is even more severe: as of May, more than a quarter of the securities on the JP Morgan Global Government Bond Index had negative yields. Events like Brexit, which create uncertainty in capital markets, are likely to suppress yields even more.

A continuing, deep low-yield environment, coupled with ongoing uncertainty in risk-seeking assets and currencies, suggests that plan sponsors will be challenged to meet their target plan returns and need to evaluate risk in their portfolios and steps to mitigate volatility, says Struthers.

"Despite the recent rebound in stocks, it's difficult to see on the horizon anything other than heightened volatility in stocks and suppressed fixed-income yields," he adds. "In this environment, active and informed risk and volatility management, including diversification, smart hedging and other de-risking strategies, should be on the minds of all pension plan sponsors."

Beyond Brexit, plans have other issues to address closer to home -- among them, the recently agreed expansion of the Canada Pension Plan (CPP), which will begin to roll out in 2019. CPP enhancement comes at a time when many defined benefit pension plans are -- or should be -- reviewing their funding formulas. With the added volatility in markets, William Da Silva, Senior Partner and National Retirement Practice Leader at Aon Hewitt, says that task has now become more challenging, and yet more vital than ever.

"Market volatility, especially when linked to high-profile events like Brexit, naturally leads plan sponsors to carefully consider their investment strategies," added Da Silva. "That's perfectly appropriate, especially in light of hedging liability movements, but they should also not lose sight of the other levers at their disposal to manage risk. With changes in the CPP coming, the long-term market outlook clouded, and 2016 being an important year for most plan sponsors in establishing minimum funding for the near future, plan sponsors should go beyond investments and consider ways to optimize their funding and benefit strategies in response to a rapidly changing pension landscape."

Aon's Median Solvency Ratio measures the financial health of a DB plan by comparing total assets to total pension liabilities in the event of plan termination. It is the most accurate and timely representation of the financial condition of Canadian DB plans because it draws on a large database and reflects each plan's specific features, investment policy, contributions and solvency relief steps taken by the plan sponsor. The analysis of the plans in the database takes into account the index performance of various asset classes, as well as the applicable interest rates to value liabilities on a solvency basis.

About Aon Aon plc ( NYSE : AON ) is a leading global provider of risk management , insurance brokerage and reinsurance brokerage, and human resources solutions and outsourcing services. Through its more than 72,000 colleagues worldwide, Aon unites to empower results for clients in over 120 countries via innovative risk and people solutions. For further information on our capabilities and to learn how we empower results for clients, please visit: http://aon.mediaroom.com .

Follow Aon Hewitt on Twitter For information on Aon plc and to sign-up for news alerts

Image Available: http://www.marketwire.com/library/MwGo/2016/7...7b3404.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/7...e03d09.jpg

Media contacts Rosa Damonte rosa.damonte@aonhewitt.com +1.416.227.5718 or Alexandre Daudelin alexandre.daudelin@aonhewitt.com +1.514.982.4910

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading